Suggestions
Dan Freed
Head of Target Discovery and Translational Research
Dan Freed is an accomplished professional with a diverse background in structural & molecular biology, biochemistry, cell signaling & network biology, cancer biology, and translational medicine.
With a Doctor of Philosophy (PhD) from the University of Virginia and a Bachelor of Science (BS) from the University of North Carolina at Wilmington, Dan has a strong educational foundation.
Currently serving as the Head of Target Discovery and Translational Research at Chordoma Foundation, Dan has previously held key roles at prominent organizations like Xilis, G1 Therapeutics, Inc., and Yale School of Medicine.
His expertise lies in developing conceptual frameworks to identify vulnerabilities in cancer and create targeted therapeutic strategies, utilizing a 'molecules-to-patients' perspective.
